Dr. Hilary Petersmeyer Bagshaw, MD

Dr. Bagshaw practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Bagshaw's NPI, 1487943916, was assigned on April 5, 2011. Dr. Bagshaw graduated from Lewis Katz School of Medicine in 2011. Dr. Bagshaw holds California license A133849.

Dr. Bagshaw's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Bagshaw's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Bagshaw is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Bagshaw to 4 more hospitals and 2 medical groups, each named with a free account. Dr. Bagshaw's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bagshaw practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Bagshaw's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Bagshaw is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Bagshaw's licenses on file in 2 states: California and Utah.

Dmand AI lists lung cancer radiation, lymphoma radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Bagshaw treats.

CMS data shows 2,118 Medicare services from Dr. Bagshaw across 23 procedure codes in 2024, for 364 Medicare patients. Medicare paid $225,499 for them.

CMS counts 364 Medicare patients who saw Dr. Bagshaw in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have cancer, and 74% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bagshaw's median patient age at 71, with 11% women.

In 2024, Dr. Bagshaw wrote 212 Medicare Part D claims for 63 patients. 92% of them were for generic drugs. CMS names the drug for 172 of them, across 4 drugs with 11 or more claims each, at $33,786 in total drug cost. In 2023, CMS named 50 claims across 2 drugs.

Dr. Bagshaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bagshaw as offering telehealth.

Dmand AI links 37 papers to Dr. Bagshaw, published from 2014 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Prostatic Neoplasms, Brachytherapy and Radiotherapy Planning, Computer-Assisted. Dr. Bagshaw has published most often in Int J Radiat Oncol Biol Phys. Dr. Bagshaw's most frequent co-authors are Mark K. Buyyounouski, MD, Steven Lee Hancock, MD and Daniel Tandel Chang, MD.

Dmand AI links Dr. Bagshaw to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Lower Urinary Tract Symptoms and Urological Manifestations.

CMS Open Payments shows 5 general payments to Dr. Bagshaw from 4 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 54% of the total. Sumitomo Pharma America, Inc. paid the most, $213.

Dmand AI lists 1 award for Dr. Bagshaw, most recently AOA Inductee 2011 in 2011.

Dr. Bagshaw graduated from Lewis Katz School of Medicine in 2011. Dr. Bagshaw is a member of AOA.

Dr. Bagshaw is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.